Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Weinstock

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma SubtypesBimarzhan Assatova, Robert Willim, Christopher Trevisani, et al.
Nature Biotechnology|June 8, 2017
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K Lewis, Luis Alvarez, et al.
Blood Cancer Discovery|March 5, 2022
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell LymphomaBethany L Mundy-Bosse, Christoph Weigel, Yue-Zhong Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|December 19, 2012
Medical planning and response for a nuclear detonation: a practical guideC Norman Coleman, Steven Adams, Carl Adrianopoli, et al.
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Cell Reports. Medicine|March 27, 2025
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, et al.
Nature|May 10, 2019
Next-generation characterization of the Cancer Cell Line EncyclopediaMahmoud Ghandi, Franklin W Huang, Judit Jané-Valbuena, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma SubtypesBimarzhan Assatova, Robert Willim, Christopher Trevisani, et al.
Nature Biotechnology|June 8, 2017
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K Lewis, Luis Alvarez, et al.
Blood Cancer Discovery|March 5, 2022
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell LymphomaBethany L Mundy-Bosse, Christoph Weigel, Yue-Zhong Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|December 19, 2012
Medical planning and response for a nuclear detonation: a practical guideC Norman Coleman, Steven Adams, Carl Adrianopoli, et al.
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Cell Reports. Medicine|March 27, 2025
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, et al.
Nature|May 10, 2019
Next-generation characterization of the Cancer Cell Line EncyclopediaMahmoud Ghandi, Franklin W Huang, Judit Jané-Valbuena, et al.
Pageof 18